International Stem Cell (ISCO) Retained Earnings (2016 - 2025)
Historic Retained Earnings for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to -$110.8 million.
- International Stem Cell's Retained Earnings fell 9.03% to -$110.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.8 million, marking a year-over-year decrease of 9.03%. This contributed to the annual value of -$110.7 million for FY2024, which is 18.92% down from last year.
- Per International Stem Cell's latest filing, its Retained Earnings stood at -$110.8 million for Q3 2025, which was down 9.03% from -$110.8 million recorded in Q2 2025.
- International Stem Cell's Retained Earnings' 5-year high stood at -$109.5 million during Q2 2021, with a 5-year trough of -$110.9 million in Q1 2025.
- In the last 5 years, International Stem Cell's Retained Earnings had a median value of -$110.4 million in 2022 and averaged -$110.3 million.
- Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 276.31% in 2021, then soared by 34.6% in 2023.
- Over the past 5 years, International Stem Cell's Retained Earnings (Quarter) stood at -$110.0 million in 2021, then fell by 0.3% to -$110.3 million in 2022, then fell by 0.12% to -$110.5 million in 2023, then dropped by 0.19% to -$110.7 million in 2024, then dropped by 0.1% to -$110.8 million in 2025.
- Its Retained Earnings was -$110.8 million in Q3 2025, compared to -$110.8 million in Q2 2025 and -$110.9 million in Q1 2025.